93 related articles for article (PubMed ID: 20538984)
1. Inflammatory cytokines in eyes with uveal melanoma and relation with macrophage infiltration.
Ly LV; Bronkhorst IH; van Beelen E; Vrolijk J; Taylor AW; Versluis M; Luyten GP; Jager MJ
Invest Ophthalmol Vis Sci; 2010 Nov; 51(11):5445-51. PubMed ID: 20538984
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor is elevated in ocular fluids of eyes harbouring uveal melanoma: identification of a potential therapeutic window.
Boyd SR; Tan D; Bunce C; Gittos A; Neale MH; Hungerford JL; Charnock-Jones S; Cree IA
Br J Ophthalmol; 2002 Apr; 86(4):448-52. PubMed ID: 11914216
[TBL] [Abstract][Full Text] [Related]
3. Uveal melanoma: the inflammatory microenvironment.
Bronkhorst IH; Jager MJ
J Innate Immun; 2012; 4(5-6):454-62. PubMed ID: 22302072
[TBL] [Abstract][Full Text] [Related]
4. Correlation of PRAME immunohistochemistry with PRAME status on gene expression profiling in enucleated uveal melanoma.
Vizcaino MA; Dalvin LA; Salomao DR
Can J Ophthalmol; 2024 Jun; 59(3):e279-e282. PubMed ID: 38114062
[No Abstract] [Full Text] [Related]
5. Tumor lysis syndrome induced by tebentafusp.
Ruf T; Leonhardt A; Anz D; Kunz WG; Röhrle N; Foerster P; Tomsitz D; French LE; Seegräber M; Heinzerling L
Immunotherapy; 2023 Nov; 15(16):1363-1368. PubMed ID: 37661909
[TBL] [Abstract][Full Text] [Related]
6. Investigating Vitreous Cytokines in Choroidal Melanoma.
Demirci H; Tang L; Demirci FY; Ozgonul C; Weber S; Sundstrom J
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509362
[TBL] [Abstract][Full Text] [Related]
7. Impact of Adjuvant Ocular Interventions on the Quality of Life of Patients with Uveal Melanoma after Proton Beam Therapy.
Gollrad J; Rabsahl C; Joussen AM; Stroux A; Budach V; Böhmer D; Böker A
Ocul Oncol Pathol; 2022 Jun; 8(2):110-119. PubMed ID: 35959158
[TBL] [Abstract][Full Text] [Related]
8.
Meng Z; Chen Y; Wu W; Yan B; Zhang L; Chen H; Meng Y; Liang Y; Yao X; Luo J
Front Immunol; 2022; 13():754645. PubMed ID: 35281030
[TBL] [Abstract][Full Text] [Related]
9. Non-Cancer Effects following Ionizing Irradiation Involving the Eye and Orbit.
Thariat J; Martel A; Matet A; Loria O; Kodjikian L; Nguyen AM; Rosier L; Herault J; Nahon-Estève S; Mathis T
Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267502
[TBL] [Abstract][Full Text] [Related]
10. Opposing Effects of Chelidonine on Tyrosine and Serine Phosphorylation of STAT3 in Human Uveal Melanoma Cells.
Csomós I; Nagy P; Filep C; Rebenku I; Nizsalóczki E; Kovács T; Vámosi G; Mátyus L; Bodnár A
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884773
[TBL] [Abstract][Full Text] [Related]
11. Traumatic Intralenticular Neovascularization in a HLA B27+ Pediatric Patient.
Tătaru CP; Tătaru CI; Dudău M; Moșu A; Luca L; Maria B; Bancu A; Curcă PF
Diagnostics (Basel); 2021 Aug; 11(8):. PubMed ID: 34441427
[TBL] [Abstract][Full Text] [Related]
12. CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of the Ligands of Receptors CCR1, CCR2, CCR3, and CCR4.
Korbecki J; Kojder K; Simińska D; Bohatyrewicz R; Gutowska I; Chlubek D; Baranowska-Bosiacka I
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182504
[TBL] [Abstract][Full Text] [Related]
13. High Cysteinyl Leukotriene Receptor 1 Expression Correlates with Poor Survival of Uveal Melanoma Patients and Cognate Antagonist Drugs Modulate the Growth, Cancer Secretome, and Metabolism of Uveal Melanoma Cells.
Slater K; Heeran AB; Garcia-Mulero S; Kalirai H; Sanz-Pamplona R; Rahman A; Al-Attar N; Helmi M; O'Connell F; Bosch R; Portela A; Villanueva A; Gallagher WM; Jensen LD; Piulats JM; Coupland SE; O'Sullivan J; Kennedy BN
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33066024
[TBL] [Abstract][Full Text] [Related]
14. Interleukins and cytokine biomarkers in uveitis.
Balamurugan S; Das D; Hasanreisoglu M; Toy BC; Akhter M; Anuradha VK; Anthony E; Gurnani B; Kaur K
Indian J Ophthalmol; 2020 Sep; 68(9):1750-1763. PubMed ID: 32823391
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia Alters the Expression of CC Chemokines and CC Chemokine Receptors in a Tumor-A Literature Review.
Korbecki J; Kojder K; Barczak K; Simińska D; Gutowska I; Chlubek D; Baranowska-Bosiacka I
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781743
[TBL] [Abstract][Full Text] [Related]
16. Immunobiology of Uveal Melanoma: State of the Art and Therapeutic Targets.
Basile MS; Mazzon E; Fagone P; Longo A; Russo A; Fallico M; Bonfiglio V; Nicoletti F; Avitabile T; Reibaldi M
Front Oncol; 2019; 9():1145. PubMed ID: 31750244
[TBL] [Abstract][Full Text] [Related]
17. Soluble HLA in the Aqueous Humour of Uveal Melanoma Is Associated with Unfavourable Tumour Characteristics.
Wierenga APA; Gezgin G; van Beelen E; Eikmans M; Spruyt-Gerritse M; Brouwer NJ; Versluis M; Verdijk RM; van Duinen SG; Marinkovic M; Luyten GPM; Jager MJ
Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31426578
[TBL] [Abstract][Full Text] [Related]
18. Uveal Melanoma Biopsy: A Review.
Frizziero L; Midena E; Trainiti S; Londei D; Bonaldi L; Bini S; Parrozzani R
Cancers (Basel); 2019 Jul; 11(8):. PubMed ID: 31366043
[TBL] [Abstract][Full Text] [Related]
19. Cytokines concentrations in aqueous humor of eyes with uveal melanoma.
Cheng Y; Feng J; Zhu X; Liang J
Medicine (Baltimore); 2019 Feb; 98(5):e14030. PubMed ID: 30702560
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy for uveal melanoma.
Kim DW; Anderson J; Patel SP
Melanoma Manag; 2016 Jun; 3(2):125-135. PubMed ID: 30190881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
